Clinical Trial Update: Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma [Phase 1]

View source ↗

Summary

This Phase I study evaluates the safety and dosing of ipilimumab given with whole-brain radiation therapy or radiosurgery in patients with recurrent or stage IV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2019-08-19